“LL-37”的搜索结果，显示 171-180 项，共有 6938 项

1. 外科 - 临床试验- 妙佑医疗国际

   Go to page 22 · Go to page 33 · Go to page 44 · Go to page 55 · Go to page 66 · NextNext Page. 以下为当前的临床试验。 120 研究外科（仅限仍在招募的研究）. 按院区 ...

2. 脑肿瘤项目- 临床试验- 妙佑医疗国际

   ... 2-year progression free survival (PFS) rate as compared to ACNS0122. ... Go to page 22 · Go to page 33 · Go to page 44 · NextNext Page · 申请预约 · 专长与排名 ...

3. 神经科- 临床试验- 妙佑医疗国际

   Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...

4. 神经科- 临床试验- 妙佑医疗国际

   ... 2 or 3 meningioma as measured by 6-month PFS rate. A Study of Demyelinating Lesions as a Cause of Progressive Motor Deterioration. Rochester, Minn. The ...

5. 神经科- 临床试验- 妙佑医疗国际

   ... 2 or 3 meningioma as measured by 6-month PFS rate. A Study of Demyelinating Lesions as a Cause of Progressive Motor Deterioration. Rochester, Minn. The ...

6. 外科 - 临床试验- 妙佑医疗国际

   Rochester, Minn. Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies. Pagination 临床研究. PrevPrevious Page · Go to page 2 ...

7. 神经科- 临床试验- 妙佑医疗国际

   ... 2 participants will also undergo MRI scanning, comprehensive cognitive ... (2) Cohort 2 focuses on primary or secondary myelofibrosis (MF) displaying ...

8. 神经科- 临床试验- 妙佑医疗国际

   Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...

9. 神经科- 临床试验- 妙佑医疗国际

   Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... 2-hydroxyglutarate (2HG) and, therefore, differentiate between IDH-mutant ... (2). Hyperplastic polyps are common but they have a low malignancy ...